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Acidic mammalian chitinase (AMCase) is induced by allergens and helminths, yet its role 23	  
in immunity is unclear.  Here, using AMCase-deficient mice, we show that while AMCase 24	  
deficiency reduced the number of type 2 innate lymphoid cells during allergen challenge, 25	  
the enzyme was not required for establishment of type 2 inflammation in the lung in 26	  
response to allergens or helminths. In contrast, AMCase-deficient mice displayed a 27	  
profound defect in type 2 immunity following infection with the chitin-containing 28	  
gastrointestinal nematodes Nippostrongylus brasiliensis and Heligmosomoides polygyrus 29	  
bakeri. The impaired immunity was associated with reduced mucus production and 30	  
decreased Il13, Chil3, Retnlb, and Clca1 mRNA expression in the intestine.  CD103+ 31	  
dendritic cells, which regulate T cell homing, were also reduced in mesenteric lymph nodes 32	  
of infected AMCase-deficient mice. Thus, AMCase functions as a critical initiator of 33	  
protective type 2 responses to intestinal nematodes, but is largely dispensable for allergic 34	  
responses in the lung. 35	  
  36	  
Chitin is the second most abundant polymer in nature, found as a structural component in fungi1, 37	  
arthropods2, and parasitic nematodes3, 4.  Mammals do not synthesize chitin, but they express two 38	  
known enzymes that digest chitin: acidic mammalian chitinase (AMCase)5 and chitotriosidase6.  39	  
AMCase is expressed in the lung and the gastrointestinal tract of humans and mice, and its 40	  
activity is markedly increased in epithelial cells and macrophages in response to the type 2 41	  
cytokines IL-4 and IL-13, yet its role in type 2 inflammation and immunity remains unclear8, 9, 10.  42	  
Most studies investigating AMCase function have focused on its role in allergic lung disease.  43	  
Mice congenitally lacking AMCase (AMCase-deficient) demonstrated little to no role for the 44	  
enzyme in acute models of house-dust mite or ovalbumin (OVA)-induced allergy in the lung11.  45	  
These findings contrasted with another published study where AMCase activity was neutralized 46	  
with allosamidin or with a monoclonal antibody and reported marked diminution of IL-13-driven 47	  
allergic inflammation, suggesting the enzyme might represent an attractive therapeutic target in 48	  
allergic asthma8.  Still, additional reports have proposed a protective role for AMCase.  One 49	  
showed the type 2 inflammatory response following chitin challenge was ameliorated in mice 50	  
overexpressing AMCase9 and another observed increased allergic lung disease in mice 51	  
specifically lacking AMCase enzymatic activity12.  The contrasting functional implications of 52	  
AMCase highlighted in these studies have yet to be fully reconciled.  Further, allergic 53	  
inflammation recapitulates the prototypic type 2 response seen after helminth infection13, but 54	  
surprisingly, despite the discovery that AMCase is highly expressed after exposure to 55	  
helminths14, it has remained unknown if the enzyme plays any role in the host immune response 56	  
to these important human pathogens.  In this study, we employed AMCase-deficient mice to 57	  
dissect the role of the enzyme in several models of helminth infection and type 2 cytokine-driven 58	  
airway inflammation.  We show that although AMCase activity is largely dispensable for the 59	  
development of allergic airway disease, the enzyme plays a critical role in the development of 60	  
type 2 immunity to the gastrointestinal nematodes Nippostrongylus brasiliensis and 61	  
Heligmosomoides polygyrus bakeri.  62	  
 63	  
Results 64	  
 65	  
Fewer ILCs but normal allergy in AMCase-deficient mice 66	  
Our initial studies were focused on reconciling the conflicting observations generated in models 67	  
of allergic lung inflammation.  We postulated that the higher doses of allergen used in a 68	  
previously published study (intranasal sensitization and challenges with 100µg house dust mite 69	  
allergen, HDM) could have masked a role for AMCase, thus accounting for the different 70	  
observations described above11, 12. Accordingly, we administered a low dose time-course 71	  
(intranasal sensitization and challenges with 25µg and 5µg HDM, respectively) to AMCase-72	  
deficient mice.  A day after the last of four challenge doses, we found the low doses of allergen 73	  
increased the lung tissue expression of Chia1, the gene encoding AMCase in wild type mice 74	  
(Fig. 1a), but that both wild type and AMCase-deficient mice exhibited similar pulmonary 75	  
inflammatory pathology (Fig. 1b).  In the tissue, AMCase abrogation had no significant impact 76	  
on leukocyte or eosinophil accumulation or gene expression of the type 2 cytokines IL-5 and IL-77	  
13 (Fig. 1c).  Also at this time-point, genes for type 2 initiators IL-33 and TSLP and for the 78	  
alternative activation markers Relmα and Mrc1 were expressed at similar levels.  Moreover, 79	  
AMCase deficiency did not alter type 2 inflammation in the airways (Fig. 1d).  To confirm these 80	  
observations were not unique to HDM, we found similar results with papain, a non-chitinous 81	  
allergen (Supplementary Fig. 1).  We also extended our studies with a chronic model of HDM-82	  
induced allergy over 6 weeks, and here too, little to no role was revealed for AMCase (Fig. 2).  83	  
These data bolster the conclusions of previous studies showing AMCase ablation does not have a 84	  
significant effect on allergic airway pathology.  They also support other reports that 85	  
chitotriosidase is the primary active chitinase in the lung 7, 15.  We were able to detect gene 86	  
expression of chitotriosidase in naive and allergic lung tissue although it was not elevated during 87	  
the allergic response (Fig. 1e).  Inquiries into whether chitotriosidase has a critical function in 88	  
lung allergy and into the differences in mice with enzymatically-deficient AMCase and mice 89	  
deficient in the entire AMCase protein remain to be answered. 90	  
Although AMCase ablation had no effect on the development of allergic disease, we 91	  
found evidence that the innate type 2 response was reduced in AMCase-deficient mice.  92	  
Following sensitization with HDM, fewer total leukocytes and fewer IL-5+IL-13+ type 2 innate 93	  
lymphoid cells (ILC2 cells) were observed in the lungs of AMCase-deficient mice (Fig. 1f).  In 94	  
addition, fewer ILCs expressed GATA-3 protein, a transcription factor critically required for the 95	  
development of ILC2s16.  Although AMCase-deficient mice ultimately overcame this defect at 96	  
later time points, for the first time, these data suggest an important role for AMCase in type 2 97	  
immune priming upstream of ILCs.  Whether this early immune priming defect explains why 98	  
polymorphisms of AMCase are associated with airway allergy requires further investigation17.  99	  
Our data indicate AMCase plays a role in type 2 immune initiation, but that the protein is not 100	  
required for establishment of type 2 allergic inflammation in the lung. 101	  
 102	  
Normal lung granuloma formation in AMCase-deficient mice 103	  
Next, we investigated the question of whether AMCase is required for the type 2 response to 104	  
helminth parasites known to increase AMCase expression14, 18.  We began by using a 105	  
Schistosoma mansoni parasite egg-induced pulmonary granuloma model, where intravenously 106	  
injected eggs that get trapped in the pulmonary vasculature trigger endothelial cell damage, 107	  
potent type 2 inflammation, and IL-4- plus IL-13-dependent granuloma formation.  S. mansoni 108	  
egg exposure led to an IL-13-dependent upregulation of Chia1, which was more robust than that 109	  
induced by HDM (Fig. 3a).  Immunofluorescence staining localized the protein expression 110	  
predominantly to bronchial epithelial cells (Fig. 3b).  Despite the marked induction of AMCase 111	  
in wild type lungs, granuloma formation (Fig. 3c), fibrosis (Fig. 3d), mucus production (Fig. 3e), 112	  
granulomatous eosinophil accumulation (Fig. 3f), and total leukocyte accumulation in 113	  
bronchoalveolar lavage fluid (BALF) (Fig. 3g) were unimpaired in AMCase-deficient mice, 114	  
demonstrating AMCase is not categorically required to mount wild type anti-parasite responses.  115	  
Likewise, intratracheal delivery of schistosome egg antigen (SEA) upregulated Chia1 in the 116	  
lung, but the type 2 response was unaffected in AMCase-deficient mice, suggesting the lack of 117	  
phenotype was not due to the route of antigen delivery (i.e. intravascular vs. epithelial exposure, 118	  
Supplementary Fig. 2).  Instead, the findings support the lung allergy studies that concluded 119	  
AMCase does not exhibit important regulatory activity in the lung. 120	  
 121	  
AMCase is critical for protection against N. brasiliensis 122	  
AMCase is highly expressed in the gastrointestinal tract (GI), but it was unknown whether 123	  
AMCase is important for the development of immunity to gastrointestinal parasites that elicit a 124	  
type 2-polarized protective immune response.  GI roundworms or nematodes, which unlike the 125	  
flatworm trematode S. mansoni, are known to contain chitin in their mouthparts, larval sheaths, 126	  
and eggshells3, 4, infect over 2 billion people, contributing to significant morbidity and mortality 127	  
worldwide19.  We sought to understand the role of AMCase in host protection using the rodent 128	  
nematode, N. brasiliensis, which has been used extensively to study and model the 129	  
immunobiology of human hookworm infestation20.  In the murine model, after subcutaneous 130	  
injection of infectious larvae, N. brasiliensis traverses the lung within 1-2 days before migrating 131	  
up the trachea and entering the GI tract where larvae mature into egg-laying adults. Wild type 132	  
mice successfully expel the worms by around 10-14 days after initial infection21.  We 133	  
enumerated the number of N. brasiliensis larvae in the wild type or AMCase-deficient guts 5, 8, 134	  
10, and 14 days post-infection. The number of worms that traversed the lungs and took residence 135	  
in the gut on day 5 was not different between AMCase-sufficient and deficient mice (Fig. 4a).  136	  
Although wild type mice nearly completely expelled the worms by day 10 as expected, AMCase-137	  
deficient mice harbored significantly more worms in the intestine and most mice did not fully 138	  
clear the infection even by day 14 (Fig. 4a).  The significantly impaired host response resulting 139	  
from AMCase deficiency was also characterized by a marked increase in the number of parasite 140	  
eggs in the feces of infected AMCase-deficient mice (Fig. 4b).   141	  
To investigate the reasons for the impairment in host defense, we harvested lung, 142	  
stomach, and intestinal tissue 8 days post-infection, the peak of expulsion in wild type mice.  In 143	  
the lung, Chia1 expression was upregulated as previously described9, but Il13 and the majority of 144	  
known effector molecules tested were expressed comparably between wild type and AMCase-145	  
deficient mice (Supplementary Fig. 3).  Only Chil3 (the gene encoding the chitinase-like 146	  
protein, Ym1) expression was significantly impaired in AMCase-deficient lungs even a few days 147	  
after worm passage—this is notable because Ym1 induces IL-17 and neutrophilic inflammation 148	  
in the lung that was postulated to compromise the fitness of N. brasiliensis larvae22.  Like the 149	  
original description of AMCase5, Chia1 expression in the intestines was undetectable, but it was 150	  
higher by at least one order of magnitude in the stomach than in the lung (Fig. 4c).  In contrast to 151	  
the lung where expression held steady, chitotriosidase gene expression was greatly diminished in 152	  
intestines of AMCase-deficient mice during N. brasiliensis infection (Fig. 4d).  Gene expression 153	  
profiling in the intestine also correlated with a broadly impaired host response to N. brasiliensis, 154	  
with AMCase-deficient mice exhibiting markedly reduced expression of Il13 and several key 155	  
downstream type 2 effector genes (Fig. 4d).  Il13 expression was reduced by more than 50%, 156	  
and Chil3 expression, upregulated over 2000-fold in infected wild type intestine, was nearly 157	  
completely abrogated, approaching the levels found in uninfected mice.  Perhaps most notably, 158	  
AMCase was necessary for normal Retnlb expression, the gene encoding another mediator that 159	  
has previously been shown to be essential for normal nematode expulsion21.  Expression of 160	  
Clca1, the gene encoding a chloride channel (Gob5) involved in mucus production23, was also 161	  
reduced.  This defect likely explains the diminished mucus production from intestinal goblet 162	  
cells, which is also critical to the development of protective immunity24 (Fig. 4e).  Accordingly, 163	  
the kinetics of N. brasiliensis clearance in the AMCase-deficient mice were similar to past 164	  
studies done in mice deficient in IL-13 signaling25, 26.  Collectively, our data show that AMCase 165	  
is necessary for mice to mount normal type 2 immunity against N. brasiliensis. 166	  
 167	  
AMCase ablation impairs type 2 immunity against H.p. bakeri 168	  
Lastly, because AMCase is expressed in the lung, we sought to explore if the defective type 2 169	  
response in AMCase-deficient mice following N. brasiliensis infection was also observed 170	  
following primary and secondary infection with H polygyrus bakeri—a rodent nematode that is 171	  
acquired orally, restricted to the GI tract, and does not migrate through the lungs.  Also, in 172	  
contrast to the N. brasiliensis model, wild type mice do not clear primary infection with H. p. 173	  
bakeri, but upon antihelminthic treatment, subsequent infections are successfully eliminated – 174	  
therefore, it is an ideal model to explore the role of AMCase in the development and 175	  
maintenance of secondary immunity.  There was a marked increase in Chia1 mRNA expression 176	  
in the stomach following infection that was absent in AMCase-deficient mice (Fig. 5a).  177	  
Moreover, as expected, there was no difference in worm recoveries between the two groups of 178	  
mice after a primary infection, but impairment of the host immune-mediated worm expulsion in 179	  
AMCase-deficient mice was strikingly apparent after a secondary infection (Fig. 5b).  Wild type 180	  
mice had nearly cleared all adult H. p. bakeri worms 15 days after re-infection, but AMCase-181	  
deficient mice still harbored an average of ~50 worms.  Even though the worm burden was not 182	  
affected by AMCase deficiency during primary infection, the fecundity of the worms differed 183	  
significantly— H. p. bakeri egg output in the AMCase-deficient mice was more than three-fold 184	  
greater than in wild type animals (Fig. 5c).  We observed higher ATP uptake in the worms 185	  
recovered from AMCase-deficient mice, correlating with the increased fecundity and suggesting 186	  
increased worm vitality (Fig. 5d).  As with N. brasiliensis infection, AMCase-deficient intestines 187	  
expressed much less Il13 after both primary and secondary H. p. bakeri infections (Fig. 5e).  188	  
This again corresponded with significantly less Chil3 and Retnlb expression in both infections.  189	  
Clca1 expression was significantly lower in AMCase-deficient mice, mirrored by less luminal 190	  
and cellular mucus in the intestines (Fig. 5f).  We ruled out that the immune defect is T cell 191	  
intrinsic by transferring CD4+ T cells from H.p. bakeri-infected wild type and AMCase-deficient 192	  
mice into H.p. bakeri-infected TCRα-deficient mice.  Recipients of cells from both cohorts were 193	  
equally competent at clearing a primary infection (Supplementary Fig. 4).   194	  
 Since we found evidence of defective immune priming in AMCase-deficient lungs (Fig 195	  
1f), we hypothesized that immune priming was also deficient in response to GI nematodes.  In 196	  
the duodenum, the type 2 alarmin Il33 was expressed at similar levels in wild type and AMCase-197	  
deficient mice in the hours after H. p. bakeri worms first reached the proximal intestine 198	  
(Supplementary Fig. 5).  Amongst the leukocytes in the mesenteric lymph node at this time, 199	  
however, we found the percentage and total number of CD103+ MHCII+ CD11b+ dendritic cells 200	  
was significantly diminished (Fig. 5g).  CD103+ DCs have been reported to have a unique 201	  
capacity to induce gut-homing activity in responding T cells in the mesenteric lymph node27.   202	  
These data show AMCase has a critical role in initiating type 2 immunity against H.p. bakeri in 203	  
the GI tract of the host. 204	  
 205	  
Discussion 206	  
 207	  
Collectively, our data indicate AMCase regulates the early priming of type 2 immune responses 208	  
in the lung and the GI tract, but that its role in generating protective anti-nematode immunity in 209	  
the GI tract is much more critical than its role in the lung.  AMCase-deficient mice and wild type 210	  
mice develop similar acute and chronic type 2-driven allergic lung pathology in response to 211	  
HDM, SEA, or papain inhalation.  AMCase ablation also had no effect on the development of 212	  
type 2-driven granuloma formation around helminth eggs in the lung.  In contrast, AMCase is 213	  
essential for optimal IL-13 production during infection with N. brasiliensis and H. p. bakeri 214	  
infection, which is required to activate downstream anti-parasite effector molecules (e.g. Ym1, 215	  
Relmβ), and mucus production that cooperatively facilitate parasite expulsion from the intestine.   216	  
It is possible that dominance of chitotriosidase in the lung might explain the different 217	  
outcomes in the lung and gut; chitotriosidase gene expression was largely unaffected by AMCase 218	  
ablation during allergen challenge but was greatly diminished in intestines of AMCase-deficient 219	  
mice during N. brasiliensis infection.  Also, because the stomach exhibits both constitutive and 220	  
IL-13-inducible AMCase activity, this might serve as the critical location for the initiation of 221	  
anti-nematode type 2 immunity as N. brasiliensis and H. p. bakeri both pass through the stomach 222	  
on their way to the intestine. Indeed, a prominent role for AMCase in the stomach and duodenum 223	  
is expected because its chitinolytic activity is greatest at low pH.  AMCase functions as a true 224	  
chitinase in the stomach as previously suggested30; therefore it is quickly transported into the 225	  
duodenum where it may aid in the disruption, release, and/or processing of parasite-associated 226	  
chitinous antigens that are critical for the initiation of protective type 2 responses in the gut.  We 227	  
found no evidence that the defective type 2 responses observed during nematode infection were 228	  
T cell intrinsic.  Instead, it is likely that the absence of AMCase results in less processing of 229	  
parasite chitin in the stomach, which would reduce the release of chitin fragments and other 230	  
antigens that serve as adjuvants for type 2 immunity9.  This is certainly consistent with the 231	  
decrease in type 2 immunity and increase in parasite load, fecundity, and worm vitality observed 232	  
in the infected AMCase-deficient mice.  Finding fewer CD103+ DCs in the intestine-draining 233	  
mesenteric lymph nodes of AMCase-deficient mice also indicates AMCase stimulates the anti-234	  
parasite immune response.  There is no existing literature about a required role for CD103+ DCs 235	  
in type 2 responses to parasites28, but there is evidence they are the major migratory dendritic 236	  
cell population that presents soluble luminal antigen to T cells29.    237	  
 AMCase has long been associated with type 2 cytokine responses that mediate 238	  
pathogenic allergic inflammation and beneficial immunity to gastrointestinal parasites.  The role 239	  
of AMCase in these widespread diseases, however, remained unclear.  We show here that 240	  
AMCase has a critical and non-redundant role in type 2 immune priming during infection with 241	  
the chitin-containing nematode parasites N. brasiliensis and H.p. bakeri.  Because AMCase 242	  
exhibited a less significant regulatory role in models of allergic lung inflammation and humans 243	  
lack the machinery to synthesize chitin, global exposure to geohelminths rather than airborne 244	  
allergens likely provided critical evolutionary pressure to preserve AMCase activity in the 245	  
human genome.  246	  
 247	  
Accession codes  248	  
Rplp2: NM_026020, Chia1: NM_023186, Il4: NM_021283, Il13: NM_008355, Chil3: 249	  
NM_009892, Relnlb: NM_023881, Retnla: NM_020509, Clca1: NM_017474, Il5: NM_010558, 250	  
Il25: NM_080729, Il33: NM_001164724, Tslp: NM_021367, Mrc1: NM_008625, Chit1: 251	  
NM_001284525. 252	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 Figure legends 376	  
 377	  
Figure 1. AMCase-deficient mice develop acute HDM-induced lung allergy despite 378	  
diminished ILC2s. 379	  
(a) Quantitative PCR analysis of AMCase gene (Chia1) expression in lung tissue from wild type 380	  
mice or AMCase-deficient mice (AMCase-KO) sensitized and challenged intranasally with PBS 381	  
(n = 9 mice per genotype) or house dust mite (HDM) (n =21 mice per genotype) expressed 382	  
relative to PBS-treated wild type. (b) Lung pathology of mice in a scored using H&E (PBS: n = 383	  
3, HDM: n = 7) and Periodic acid-Schiff (PAS) (PBS: n = 6, HDM: n = 15; pooled from 2 384	  
experiments) stains (scale bars=100µm). (c) Lung tissue leukocyte (PBS: n = 6, HDM: n = 15 385	  
pooled from 2 experiments) and eosinophil quantification (PBS: n = 9, HDM: n = 22; pooled 386	  
from 3 experiments) from three lung lobes of mice in a and gene expression analysis (PBS: n = 387	  
9, HDM: n = 22; pooled from 3 experiments). (d) Leukocyte and eosinophil quantification and 388	  
intracellular cytokine analysis of lymphocytes collected from bronchoalveolar lavage fluid 389	  
(BALF) of mice in a (PBS: n = 9, HDM: n = 22). (e) Chitotriosidase gene expression in lung 390	  
tissue (representative of naive and allergic lungs) (wild type: n = 3, AMCase-KO: n = 3) shown 391	  
relative to expression of the housekeeping gene, Rplp2. (f) Quantification of total lung 392	  
leukocytes, IL-4+IL-13+ type 2 innate lymphoid cells (ILC2s), and Gata3+ cells amongst ILCs 393	  
from wild type or AMCase-KO mice intranasally sensitized with PBS (n = 3) or HDM (n =7).  394	  
*P<0.05, **P<0.01 (Student’s t-test). Data are pooled from three experiments (a,d) or are from 395	  
one experiment representative of three independent experiments with similar results (e,f). Error 396	  
bars represent standard error of the mean, and each data point represents a value for an individual 397	  
mouse. 398	  
 399	  
Figure 2. Chronic HDM induces similar allergy in lungs of wild type and AMCase-deficient 400	  
mice. 401	  
(a) Histopathology scoring and representative sections stained with H&E (scale bars=200µm) 402	  
from wild type or AMCase-KO mice sensitized and challenged intranasally with PBS (n = 3 403	  
mice per genotype) or house dust mite (HDM) (n = 8 mice per genotype) for 45d. (b) 404	  
Quantification of eosinophils in lung tissue of mice in a (PBS: n = 3, HDM: n = 9). (c) 405	  
Intracellular cytokine analysis of lung tissue lymphocytes of mice in a (PBS: n = 3, HDM: n = 406	  
9). (d) Quantification of eosinophils in BALF of mice in a (PBS: n = 3, HDM: n = 9). (e) 407	  
Intracellular cytokine analysis of BALF lymphocytes of mice in a (PBS: n = 3, HDM: n = 9).  408	  
Data are pooled from two experiments with similar results. Error bars represent standard error of 409	  
the mean, and each data point represents a value for an individual mouse. 410	  
 411	  
Figure 3. AMCase-deficient mice develop S. mansoni egg-induced lung granulomas. 412	  
(a) Quantitative PCR analysis of Chia1 expression in lung tissue from wild type mice (n = 5) or 413	  
IL-13-deficient mice (IL-13-KO) (n = 5) seven days after intravenous injection of S. mansoni 414	  
eggs. (b) Immunofluorescence of lung airway sections seven days after intravenous egg 415	  
injection. (c) Four or seven days after intravenous egg injection into wild type (D4: n = 8, D7: n 416	  
= 11) or AMCase-KO mice (D4: n = 11, D7: n = 10), granulomatous lung pathology was 417	  
measured using Giemsa stain. (d) Lung sections from mice in c scored for fibrosis by Picrosirius 418	  
stain. (e) Lung sections from mice in c scored for mucus in goblet cells by PAS stain. (f) 419	  
Quantification of eosinophils comprising granulomas from Giemsa-stained lung sections of mice 420	  
in c.  (g) Quantification of BALF cells from mice in c.  Scale bar=50 µm (b), 100 µm (c,d,e). 421	  
Data are representative of two experiments with similar results. Error bars represent standard 422	  
error of the mean, and each data point represents a value for an individual mouse. 423	  
 424	  
Figure 4. AMCase is critical for type 2-mediated protection against N. brasiliensis. 425	  
(a) Quantification of nematodes from intestines of wild type or AMCase-KO mice (n = 5 per 426	  
genotype per time-point) on days after infection. (b) Fecal egg counts (D6: n = 14 mice per 427	  
genotype; D7: n = 14 per genotype; D8: n = 13 per genotype; D9: n = 8 per genotype; D10: n = 8 428	  
per genotype) (c) Quantitative PCR analysis of Chia1 expression in tissues from naïve wild type 429	  
mice (n = 3) shown relative to expression of the housekeeping gene, Rplp2., (d) Quantitative 430	  
PCR analysis of gene expression in small intestinal tissue of wild-type mice (n = 7) or AMCase-431	  
KO mice (n = 7) 8 days post-N.brasiliensis infection shown relative to expression in naïve mice.  432	  
(e) Representative PAS staining from small intestinal sections from mice in d (scale bar=100 433	  
µm).  *P<0.05, **P<0.01, ***P<0.001 (Student’s t-test). Data are representative of two 434	  
experiments with similar results. Error bars represent standard error of the mean, and each data 435	  
point represents a value for an individual mouse. 436	  
 437	  
Figure 5. Type 2 immunity is impaired against H. p. bakeri in AMCase-deficient mice. 438	  
(a) Quantitative PCR analysis of Chia1 expression in stomach tissue from wild type mice (n = 7) 439	  
or AMCase-KO mice (n = 6) 15 days after primary infection with H. p. bakeri. (b) Adult worm 440	  
burden in the intestines 15 days after primary (1o) or secondary (2o) challenge of wild type mice 441	  
(n = 8) or AMCase-KO mice (n = 7). (c) Fecal egg counts 12 days after primary or secondary 442	  
challenge of wild type mice (n = 8) or AMCase-KO mice (n = 7). (d) Adult worm ATP levels 12 443	  
days post-primary challenge of wild type mice (n = 2) or AMCase-KO mice (n = 7).  (e) 444	  
Quantitative PCR analysis of gene expression in small intestinal tissue of wild-type mice (n = 7) 445	  
or AMCase-KO mice (n = 7) 12 days post-infection shown relative to expression in naïve mice. 446	  
(f) PAS staining of representative small intestinal tissue sections 12 days post-secondary 447	  
challenge (scale bar=200µm; arrows indicate parasites). (g) Quantification of mesenteric lymph 448	  
node dendritic cells from wild type mice (n = 8) or AMCase-KO mice (n = 7) 3.5 days post-449	  
infection (Inf) or from uninfected (UI) wild type or AMCase-KO (n = 3 per genotype). *P<0.05, 450	  
**P<0.01, ***P<0.001 (Student’s t-test). Data are representative of two experiments with 451	  
similar results. Error bars represent standard error of the mean, and each data point represents a 452	  
value for an individual mouse. 453	  
 454	  
Online Methods 455	  
 456	  
Animals 457	  
The National Institute of Allergy and Infectious Diseases Division of Intramural Research 458	  
Animal Care and Use Program, as part of the National Institutes of Health Intramural Research 459	  
Program, approved all of the experimental procedures (protocol “LPD 16E”).  The Program 460	  
complies with all applicable provisions of the Animal Welfare Act 461	  
(http://www.aphis.usda.gov/animal_welfare/downloads/awa/awa.pdf) and other federal statutes 462	  
and regulations relating to animals.  AMCase-deficient mice on a C57BL/6N background were 463	  
kindly provided by Lori Fitz and Pfizer.  Wild type C57BL/6N mice, and IL-13-deficient and 464	  
TCRα-deficient mice on a C57BL/6N background, were obtained from Taconic Farms Inc. Male 465	  
and female mice between the ages of 6 weeks and 12 weeks were used randomly to begin 466	  
experimental models because of limited availability, and no sex-specific differences were 467	  
observed.  Groups in individual experiments were sex-matched and age-matched.  All animals 468	  
were housed under specific pathogen-free conditions at the National Institutes of Health in an 469	  
American Association for the Accreditation of Laboratory Animal Care-approved facility.   470	  
 471	  
S. mansoni egg-induced lung granuloma model 472	  
5000 S. mansoni eggs (Biomedical Research Institute) were injected intraperitoneally on day 0 to 473	  
sensitize mice.  On day 14, mice were challenged intravenously with 5000 live eggs containing 474	  
mature embryos again before lungs were harvested on day 18 or 21. 475	  
 476	  
Schistosome egg antigen-induced lung inflammation model 477	  
Schistosome egg antigen (SEA) was obtained from sterile LPS-free liver-derived eggs from mice 478	  
chronically infected with Schistosoma mansoni.  Mice were intratracheally sensitized and 479	  
challenged with 10 µg SEA on days 0, 7, 14, 16, and 18.  SEA was administered in 30 µl saline 480	  
to mice anesthetized with isoflurane.  Lungs were lavaged and harvested for analysis on day 19.   481	  
 482	  
Acute house dust mite allergen-induced lung inflammation model 483	  
Mice were intranasally sensitized with 25 µg of house dust mite (HDM, Greer) or PBS on days 484	  
0, 1, and 2.  On days 15, 16, 17, and 18, mice were intranasally challenged with 5 µg of HDM or 485	  
PBS.  HDM was administered in 30 µl PBS to mice anesthetized with isoflurane. Lungs were 486	  
lavaged and harvested for analysis on day 19.   487	  
 488	  
Chronic house dust mite allergen-induced lung inflammation model 489	  
Mice were intranasally sensitized with 25 µg of house dust mite (HDM, Greer) or PBS on days 490	  
0, 1, and 2.  On days 14, 15, 16, 28, 29, 30, 42, 43, and 44, mice were intranasally challenged 491	  
with 5 µg of HDM or PBS.  Lungs were lavaged and harvested for analysis on day 45.   492	  
 493	  
Acute papain-induced lung inflammation model 494	  
Mice were intranasally sensitized with 12.5 µg of papain (Carica papaya, EMD Millipore) or 495	  
water on days 0, 1, and 2.  On days 15, 16, 17, and 18, mice were intranasally challenged with 10 496	  
µg of papain or PBS.  Papain was administered in 30 µl PBS to mice anesthetized with 497	  
isoflurane. Lungs were lavaged and harvested for analysis on day 19.   498	  
 499	  
Nippostrongylus brasiliensis infection 500	  
Third-stage (L3) larvae were prepared as described previously31, and 500 were injected 501	  
subcutaneously into the nape of the neck of each mouse.  Feces were collected on days 6-10 502	  
post-infection for egg counts.  Adult worms were counted in the small intestine on days 5, 8, 10, 503	  
or 14.  Representative sections of lung and small intestinal tissue were taken for histology and 504	  
qPCR analysis on day 8. 505	  
 506	  
Heligmosomoides polygyrus bakeri infection 507	  
As described previously32, mice were inoculated periorally with 200 L3, and 2 weeks later, 508	  
worms were expelled by administering 1-2 mg pyrantal pamoate.  4 weeks later, the sensitized 509	  
mice were challenged with H. p. bakeri (secondary) while naive mice were inoculated with 200 510	  
L3 for the first time as controls (primary).  12 days after this, mice were sacrificed for analysis.  511	  
Eggs were counted in the feces, and tissue was collected for histology and gene expression assay 512	  
by qPCR.  Adult worms were counted in the intestines 15 days after primary inoculation and 513	  
secondary challenge. The ATPLite Luminescence Assay System (Perkin Elmer) was used to 514	  
measure ATP content of adult worms collected from the intestines of primary infected mice.  For 515	  
some experiments, the proximal small intestine and mesenteric lymph nodes were harvested 3.5 516	  
days post-infection for studies of the innate immune response. 517	  
 518	  
T cell transfer 519	  
Wild type and AMCase-deficient mice were subjected to primary H. p. bakeri infection with 200 520	  
L3.  Two weeks later, mesenteric lymph nodes were harvested and ground into a single cell 521	  
suspension through a 70 µm filter on ice.  CD4+ T cells were isolated from the leukocytes using 522	  
Dynabeads Untouched Mouse CD4 Cells kit (Invitrogen).  TCRα-deficient mice were infected 523	  
with H. p. bakeri and on the same day were injected intravenously with 2x105 T cells from wild 524	  
type mice, 2x105 T cells from AMCase-deficient mice, or no T cells.  H.p. bakeri adult worms 525	  
were counted from the recipient mice 15 days later. 526	  
 527	  
Bronchoalveolar lavage 528	  
1 ml of ice-cold PBS supplemented with 5 mM EDTA was injected through the trachea into the 529	  
lungs and aspirated using a syringe. 530	  
 531	  
Histopathology  532	  
Representative samples of lung or intestinal tissue were fixed in Bouin-Hollande solution, 533	  
embedded in paraffin for sectioning, and stained (Histopath of America) with Wright’s Giemsa 534	  
to measure eosinophil accumulation, hematoxylin and eosin to analyze inflammation, Picrosirius 535	  
red to analyze fibrosis, or Periodic acid-Schiff (PAS) stain for analysis of mucus production.  A 536	  
blinded pathologist measured the diameter of approximately 30 granulomas and quantified 537	  
granulomatous eosinophils in Giemsa-stained sections of each sample with granulomatous 538	  
pathology.  The blinded pathologist also scored the stained sections for fibrosis and mucus 539	  
production.  Images were scanned at 40X with an Aperio ScanScope (Leica Biosystems). 540	  
 541	  
Immunofluorescence staining and microscopy 542	  
Immunodetection of AMCase was performed on lung and intestinal tissue sections with rabbit 543	  
sera immunized against recombinant murine AMCase that was a gift from MedImmune.  544	  
MedImmune validated the antisera in-house for use in mice. 545	  
 546	  
Leukocyte isolation from lung tissue for analysis by flow cytometry  547	  
About 200 mg of lung tissue was ground into a single-cell suspension through a 100-µm nylon 548	  
mesh. Leukocytes were separated on a 40% Percoll (Sigma-Aldrich) gradient (2000 rpm for 15 549	  
min) and treated for 2 min with 1 ml ACK (ammonium chloride–potassium bicarbonate) lysis 550	  
buffer to lyse erythrocytes.  After 3 hours of stimulation with phorbol 12-myristate13-acetate 551	  
(PMA, 10 ng/ml), ionomycin (1 µg/ml), and Brefeldin A (BFA, 10 µg/ml), leukocytes were 552	  
fixed and permeabilized for 30 minutes (Cytofix/Cytoperm buffer; BD Biosciences) and then 553	  
stained for 30 minutes with antibodies for CD4 (1:200 dilution; RM4-5; eBioscience), IL-4 554	  
(1:200 dilution; 11B11; eBioscience), IL-5 (1:200 dilution; TRFK5; BD Pharmingen), and IL-13 555	  
(1:200 dilution; eBio13A; eBioscience) diluted in the Permwash buffer (BD Biosciences). 556	  
Unstimulated lung leukocyte aliquots were set aside and stained for 30 minutes with anti-SiglecF 557	  
(1:200 dilution; E50-2440; BD Biosciences). Positive SiglecF staining and scatter profiling were 558	  
used to identify eosinophils by flow cytometry. Expression of CD4, SiglecF, and the intracellular 559	  
cytokines was analyzed with a BD FACSCanto II flow cytometer and FlowJo v.7.6 software 560	  
(Tree Star).  For some experiments, leukocytes were isolated as above approximately 12 hours 561	  
after the last of three sensitization doses of house dust mite.  Some cells were stimulated as 562	  
described above, washed with Hank’s Balanced Salt Solution, and stained with Live/Dead 563	  
Fixable Blue (Life Technologies), anti-CD16/32 (1:500 dilution; Biolegend), and a biotin-564	  
conjugated lineage cocktail (1:100 dilution; eBioscience) composed of antibodies against CD8 565	  
(eBioH35-17.2), CD11b (M1/70), CD19 (MB19-1), CD49b (DX5), Gr-1 (RB6-8C5), NK1.1 566	  
(PK136), γδTCR (eBioGL3), TER-119, and CD11c (N418) for 20 minutes at 4oC.  Next, cells 567	  
were washed with FACS buffer and stained with a streptavidin-conjugated antibody and 568	  
antibodies against CD16/32, Thy1.2 (1:400 dilution; 53-2.1; Biolegend), CD45 (1:400 dilution; 569	  
30-F11; Biolegend), and TCRβ (1:200 dilution; H57-597; eBioscience) for 30 minutes at 4oC.  570	  
The cells were washed again with FACS buffer before being fixed with 2% paraformaldehyde 571	  
for 15 minutes at room temperature.  Cells were then permeabilized by washing with 0.5% 572	  
saponin (Sigma) and stained with antibodies for CD4 (1:500 dilution; RM4-5; BDBioscience), 573	  
IL5 (1:200 dilution), IL13 (1:100 dilution), and CD16/32 (1:500 dilution) in the same buffer for 574	  
45 minutes at 4oC.  The cells were again washed in 0.5% saponin before being resuspended in 575	  
FACS buffer for analysis with a BD LSRFortessa flow cytometer.  Type 2 innate lymphoid cells 576	  
were identified as live Lin– TCRβ– CD4– Thy1.2+ CD45+ IL-5+ IL-13+.  Some cells were left 577	  
unstimulated for measurement of Gata3 expression.  These cells were processed as above until 578	  
they were permeabilized with Fixation/Permeabilization solution (eBioscience) and then stained 579	  
with antibodies against CD4 (1:400 dilution; RM4-5; Biolegend) and Gata3 (1:40 dilution; L50-580	  
823; BDBiosciences) and washed with permeabilization buffer (eBioscience).  Gata3+ innate 581	  
lymphoid cells were also identified with a BD LSRFortessa.  All antibodies are commercially 582	  
available, and validation profiles and references are available on corresponding commercial 583	  
websites. 584	  
 585	  
Leukocyte isolation from mesenteric lymph nodes for dendritic cell identification  586	  
3.5 days post-infection with H.p. bakeri, mesenteric lymph nodes were ground into a single-cell 587	  
suspension through a 70-µm cell strainer on ice.  Leukocytes were fixed and then stained for 30 588	  
minutes with antibodies for CD16/32 (1:100 dilution; BDBiosciences), CD45 (1:200 dilution; 589	  
30-F11; Biolegend), Ly6G (1:400 dilution; 1A8; BD Pharmingen), CD11c (1:200 dilution; 3.9; 590	  
Biolegend), MHCII 1Ab (1:200 dilution; M5/114.15.2; eBioscience), CD11b (1:200 dilution; 591	  
M1/70; Biolegend), and CD103 (1:200 dilution; M290; BDBiosciences).  CD45+ Ly6G– CD11c+ 592	  
MHCII+ CD11b+ CD103+ cells were identified with a BD LSRFortessa and FlowJo v.7.6 593	  
software.  All antibodies are commercially available, and validation profiles and references are 594	  
available on corresponding commercial websites. 595	  
 596	  
RNA isolation and quantitative real-time PCR  597	  
Lung, stomach, or intestinal tissue was homogenized in TRIzol Reagent (Life Technologies) 598	  
using Precellys 24 (Bertin Technologies). Total RNA was extracted from the homogenate by 599	  
addition of chloroform followed by the recommendations of the MagMax-96 Total RNA 600	  
Isolation Kit (Life Technologies).  RNA was then reverse transcribed using SuperScript II 601	  
Reverse Transcriptase (Life Technologies).  Real-time RT-PCR was performed on an ABI Prism 602	  
7900HT Sequence Detection System (Applied Biosystems). Quantities of mRNA expressed by a 603	  
particular gene were determined using Power SYBR Green PCR Master Mix (Applied 604	  
Biosystems), normalized to ribosomal protein, large, P2 (RPLP2) mRNA levels in each sample, 605	  
and then articulated as a relative increase or decrease compared with mRNA levels expressed by 606	  
the same gene in naive controls.  We used the following primer sequences: Rplp2: forward – 5’-607	  
TACGTCGCCTCTTACCTGCT-3’, reverse-5’- GACCTTGTTGAGCCGATCAT-3’; Chia1: 608	  
forward -5’- TGGACCTGGACTGGGAATACC-3’, reverse-5’- TGGGCCTGTTGCTCTCAATAG-609	  
3’; Il4: forward -5’- ACGAGGTCACAGGAGAAGGGA-3’, reverse-5’- 610	  
AGCCCTACAGACGAGCTCACTC-3’; Il13: forward -5’- CCTCTGACCCTTAAGGAGCTTAT-611	  
3’, reverse-5’- CGTTGCACAGGGGAGTCT-3’; Chil3: forward -5’-612	  
CATGAGCAAGACTTGCGTGAC-3’, reverse-5’- GGTCCAAACTTCCATCCTCCA-3’; Relnlb: 613	  
forward -5’- CGTCTCCCTTTTCCCACTG-3’, reverse-5’- CAGGAGATCGTCTTAGGCTCTT-3’; 614	  
Retnla: forward -5’-CCCTCCACTGTAACGAAGACTC-3’, reverse-5’- 615	  
CACACCCAGTAGCAGTCATCC-3’; Clca1: forward -5’- AGGAAAACCCCAAGCAGTG-3’, 616	  
reverse-5’- GCACCGACGAACTTGATTTT-3’; Il5: forward – 5’- 617	  
TGACAAGCAATGAGACGATGAGG -3’, reverse-5’- ACCCCCACGGACAGTTTGATTC -3’; 618	  
Il33: forward – 5’- CACATTGAGCATCCAAGGAA -3’, reverse-5’- 619	  
AACAGATTGGTCATTGTATGTACTCAG -3’; Tslp: forward – 5’- 620	  
ACGGATGGGGCTAACTTACAA -3’, reverse-5’- AGTCCTCGATTTGCTCGAACT -3’; Il25: 621	  
forward – 5’- ACAGGGACTTGAATCGGGTC -3’, reverse-5’- TGGTAAAGTGGGACGGAGTTG 622	  
-3’; Mrc1: forward – 5’- CCCAAGGGCTCTTCTAAAGCA 623	  
 -3’, reverse-5’- CGCCGGCACCTATCACA -3’; Chit1: forward – 5’- TGGGCAGGTGTGATGACTCT 624	  
-3’, reverse-5’- CCCTGGGAAAGAACCGAACTG -3’. 625	  
 626	  
Statistical analysis  627	  
All data were analyzed with Prism (Version 5; GraphPad). Data sets were compared with a two-628	  
tailed t-test, and differences were considered significant if P values were less than 0.05.  No 629	  
statistical methods were used to predetermine sample size.  Group sample size was chosen using 630	  
records of variance in past experiments, and variance is similar between groups being 631	  
statistically compared.  Mice or samples were randomly assigned to experimental groups or 632	  
processing orders.  Group allocation was blinded for all mouse work, when possible (e.g. 633	  
administration of allergens and infectious agents, sample quantification and analysis, pathology 634	  
scoring).  Samples or data points were excluded only in the case of a technical equipment or 635	  
human error that caused a sample to be poorly controlled for. 636	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